APO RESEARCH · REPORT
Animal Model for Testing
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Product & engineering
Understand the product.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
In our report, all the animals used in scientific purposes are included.
Selected research
Market Structure
Global Animal Model for Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
In our report, all the animals used in scientific purposes are included.
Read the full market overview
Global Animal Model for Testing key players include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, etc. Global top four manufacturers hold a share about 45%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share over 50 percent.
In terms of product, Mice is the largest segment, with a share over 60%. And in terms of application, the largest application is Pharmaceutical and Biotechnology Companies, followed by Academic and Research Institutes.
Report Includes
This report provides an overview of the global Animal Model for Testing market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Animal Model for Testing and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Animal Model for Testing revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Animal Model for Testing market size, projected growth trends, production technologies, key applications, and end-use industries.
Animal Model for Testing Segment by Company
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
Animal Model for Testing Segment by Type
Rats
Mice
Others
Animal Model for Testing Segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Animal Model for Testing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Model for Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Model for Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Model for Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Animal Model for Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Animal Model for Testing industry.
Chapter 3: Detailed analysis of Animal Model for Testing companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Model for Testingrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Rats
- Mice
- Others
Applications
- Academic and Research Institutes
- Pharmaceutical and Biotechnology Companies
Companies covered
- Charles River Laboratories
- Envigo
- Taconic Biosciences
- Jackson Laboratory
- Crown Biosciences
- Shanghai SLAC
- Shangghai Modelorg
- GenOway
- Syngene International
- Psychogenics
- Pharmaron
- Pharmalegacy
- Vitalstar Biotechnology
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Animal Model for Testing Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Rats
- 1.2.3 Mice
- 1.2.4 Others
- 1.3 Market Analysis by Application
- 1.3.1 Global Animal Model for Testing Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Academic and Research Institutes
- 1.3.3 Pharmaceutical and Biotechnology Companies
- 1.4 Global Market Growth Prospects
- 1.5 Global Animal Model for Testing Growth Trends by Region
- 1.5.1 Global Animal Model for Testing Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Animal Model for Testing Market Size by Region (2021-2026)
- 1.5.3 Animal Model for Testing Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Animal Model for Testing Market Dynamics
- 2.1 Animal Model for Testing Industry Trends
- 2.2 Animal Model for Testing Industry Drivers
- 2.3 Animal Model for Testing Industry Opportunities and Challenges
- 2.4 Animal Model for Testing Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Animal Model for Testing Revenue by Company (2021-2026)
- 3.2 Global Animal Model for Testing Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Animal Model for Testing Key Company Head office and Area Served
- 3.4 Global Animal Model for Testing Company, Product Type & Application
- 3.5 Global Animal Model for Testing Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Animal Model for Testing Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Animal Model for Testing Players Market Share by Revenue in 2025
- 3.6.3 2025 Animal Model for Testing Tier 1, Tier 2, and Tier 3
4 Animal Model for Testing Market by Type
- 4.1 Global Animal Model for Testing Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Animal Model for Testing Market Size by Type (2021-2032)
- 4.3 Global Animal Model for Testing Market Size Share by Type (2021-2032)
5 Animal Model for Testing Market by Application
- 5.1 Global Animal Model for Testing Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Animal Model for Testing Market Size by Application (2021-2032)
- 5.3 Global Animal Model for Testing Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Charles River Laboratories
- 6.1.1 Charles River Laboratories Company Information
- 6.1.2 Charles River Laboratories Business Overview
- 6.1.3 Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Charles River Laboratories Animal Model for Testing Product Portfolio
- 6.1.5 Charles River Laboratories Recent Developments
- 6.2 Envigo
- 6.2.1 Envigo Company Information
- 6.2.2 Envigo Business Overview
- 6.2.3 Envigo Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Envigo Animal Model for Testing Product Portfolio
- 6.2.5 Envigo Recent Developments
- 6.3 Taconic Biosciences
- 6.3.1 Taconic Biosciences Company Information
- 6.3.2 Taconic Biosciences Business Overview
- 6.3.3 Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Taconic Biosciences Animal Model for Testing Product Portfolio
- 6.3.5 Taconic Biosciences Recent Developments
- 6.4 Jackson Laboratory
- 6.4.1 Jackson Laboratory Company Information
- 6.4.2 Jackson Laboratory Business Overview
- 6.4.3 Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Jackson Laboratory Animal Model for Testing Product Portfolio
- 6.4.5 Jackson Laboratory Recent Developments
- 6.5 Crown Biosciences
- 6.5.1 Crown Biosciences Company Information
- 6.5.2 Crown Biosciences Business Overview
- 6.5.3 Crown Biosciences Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Crown Biosciences Animal Model for Testing Product Portfolio
- 6.5.5 Crown Biosciences Recent Developments
- 6.6 Shanghai SLAC
- 6.6.1 Shanghai SLAC Company Information
- 6.6.2 Shanghai SLAC Business Overview
- 6.6.3 Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Shanghai SLAC Animal Model for Testing Product Portfolio
- 6.6.5 Shanghai SLAC Recent Developments
- 6.7 Shangghai Modelorg
- 6.7.1 Shangghai Modelorg Company Information
- 6.7.2 Shangghai Modelorg Business Overview
- 6.7.3 Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Shangghai Modelorg Animal Model for Testing Product Portfolio
- 6.7.5 Shangghai Modelorg Recent Developments
- 6.8 GenOway
- 6.8.1 GenOway Company Information
- 6.8.2 GenOway Business Overview
- 6.8.3 GenOway Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 GenOway Animal Model for Testing Product Portfolio
- 6.8.5 GenOway Recent Developments
- 6.9 Syngene International
- 6.9.1 Syngene International Company Information
- 6.9.2 Syngene International Business Overview
- 6.9.3 Syngene International Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Syngene International Animal Model for Testing Product Portfolio
- 6.9.5 Syngene International Recent Developments
- 6.10 Psychogenics
- 6.10.1 Psychogenics Company Information
- 6.10.2 Psychogenics Business Overview
- 6.10.3 Psychogenics Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Psychogenics Animal Model for Testing Product Portfolio
- 6.10.5 Psychogenics Recent Developments
- 6.11 Pharmaron
- 6.11.1 Pharmaron Company Information
- 6.11.2 Pharmaron Business Overview
- 6.11.3 Pharmaron Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Pharmaron Animal Model for Testing Product Portfolio
- 6.11.5 Pharmaron Recent Developments
- 6.12 Pharmalegacy
- 6.12.1 Pharmalegacy Company Information
- 6.12.2 Pharmalegacy Business Overview
- 6.12.3 Pharmalegacy Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Pharmalegacy Animal Model for Testing Product Portfolio
- 6.12.5 Pharmalegacy Recent Developments
- 6.13 Vitalstar Biotechnology
- 6.13.1 Vitalstar Biotechnology Company Information
- 6.13.2 Vitalstar Biotechnology Business Overview
- 6.13.3 Vitalstar Biotechnology Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Vitalstar Biotechnology Animal Model for Testing Product Portfolio
- 6.13.5 Vitalstar Biotechnology Recent Developments
7 North America
- 7.1 North America Animal Model for Testing Market Size (2021-2032)
- 7.2 North America Animal Model for Testing Market Size by Type
- 7.2.1 North America Animal Model for Testing Market Size by Type (2021-2026)
- 7.2.2 North America Animal Model for Testing Market Size by Type (2027-2032)
- 7.2.3 North America Animal Model for Testing Market Share by Type (2021-2032)
- 7.3 North America Animal Model for Testing Market Size by Application
- 7.3.1 North America Animal Model for Testing Market Size by Application (2021-2026)
- 7.3.2 North America Animal Model for Testing Market Size by Application (2027-2032)
- 7.3.3 North America Animal Model for Testing Market Share by Application (2021-2032)
- 7.4 North America Animal Model for Testing Market Size by Country
- 7.4.1 North America Animal Model for Testing Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Animal Model for Testing Market Size by Country (2021-2026)
- 7.4.3 North America Animal Model for Testing Market Size by Country (2027-2032)
- 7.4.4 North America Animal Model for Testing Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Animal Model for Testing Market Size (2021-2032)
- 8.2 Europe Animal Model for Testing Market Size by Type
- 8.2.1 Europe Animal Model for Testing Market Size by Type (2021-2026)
- 8.2.2 Europe Animal Model for Testing Market Size by Type (2027-2032)
- 8.2.3 Europe Animal Model for Testing Market Share by Type (2021-2032)
- 8.3 Europe Animal Model for Testing Market Size by Application
- 8.3.1 Europe Animal Model for Testing Market Size by Application (2021-2026)
- 8.3.2 Europe Animal Model for Testing Market Size by Application (2027-2032)
- 8.3.3 Europe Animal Model for Testing Market Share by Application (2021-2032)
- 8.4 Europe Animal Model for Testing Market Size by Country
- 8.4.1 Europe Animal Model for Testing Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Animal Model for Testing Market Size by Country (2021-2026)
- 8.4.3 Europe Animal Model for Testing Market Size by Country (2027-2032)
- 8.4.4 Europe Animal Model for Testing Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Animal Model for Testing Market Size (2021-2032)
- 9.2 China Animal Model for Testing Market Size by Type
- 9.2.1 China Animal Model for Testing Market Size by Type (2021-2026)
- 9.2.2 China Animal Model for Testing Market Size by Type (2027-2032)
- 9.2.3 China Animal Model for Testing Market Share by Type (2021-2032)
- 9.3 China Animal Model for Testing Market Size by Application
- 9.3.1 China Animal Model for Testing Market Size by Application (2021-2026)
- 9.3.2 China Animal Model for Testing Market Size by Application (2027-2032)
- 9.3.3 China Animal Model for Testing Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Animal Model for Testing Market Size (2021-2032)
- 10.2 Asia Animal Model for Testing Market Size by Type
- 10.2.1 Asia Animal Model for Testing Market Size by Type (2021-2026)
- 10.2.2 Asia Animal Model for Testing Market Size by Type (2027-2032)
- 10.2.3 Asia Animal Model for Testing Market Share by Type (2021-2032)
- 10.3 Asia Animal Model for Testing Market Size by Application
- 10.3.1 Asia Animal Model for Testing Market Size by Application (2021-2026)
- 10.3.2 Asia Animal Model for Testing Market Size by Application (2027-2032)
- 10.3.3 Asia Animal Model for Testing Market Share by Application (2021-2032)
- 10.4 Asia Animal Model for Testing Market Size by Country
- 10.4.1 Asia Animal Model for Testing Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Animal Model for Testing Market Size by Country (2021-2026)
- 10.4.3 Asia Animal Model for Testing Market Size by Country (2027-2032)
- 10.4.4 Asia Animal Model for Testing Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Animal Model for Testing Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Animal Model for Testing Market Size by Type
- 11.2.1 South America, Middle East & Africa Animal Model for Testing Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Animal Model for Testing Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Animal Model for Testing Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Animal Model for Testing Market Size by Application
- 11.3.1 South America, Middle East & Africa Animal Model for Testing Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Animal Model for Testing Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Animal Model for Testing Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Animal Model for Testing Market Size by Country
- 11.4.1 South America, Middle East & Africa Animal Model for Testing Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Animal Model for Testing Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Animal Model for Testing Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Animal Model for Testing Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst